|

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

RECRUITINGN/ASponsored by Lo.Li.Pharma s.r.l
Actively Recruiting
PhaseN/A
SponsorLo.Li.Pharma s.r.l
Started2024-02-19
Est. completion2026-03
Eligibility
Age25 Years – 65 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06285357

Summary

The purpose of the study is to test the effect of the administration of a dietary supplement consisting of epigallocatechin gallate (EGCG), vitamin B12 and folic acid in the treatment of infections with papilloma virus of the cervix.

Eligibility

Age: 25 Years – 65 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* HR-HPV DNA test positivity

Exclusion Criteria:

* No HSIL

Conditions2

CancerHPV Infection

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.